Follow The Filings

KLRA Kailera Therapeutics Inc.

Health Care, filed as KAILERA THERAPEUTICS INC (COMMON STOCK), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 3 Owners
  • Max 0.3%
  • $26M
  • 3 new

In 2026 Q2 David Witzke, Farallon Capital Management, and George Soros opened positions in Kailera Therapeutics.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (David Witzke, Avidity Partners Management). Not free-float ownership.

  1. David Witzke New 0.28%
  2. Farallon Capital Management New 0.11%
  3. George Soros New 0.01%

Who owns KLRA

Sorted by value, long equity only, as of 2026 Q2.

History
Farallon Capital Management 0.11% New 0.11% 1,100,000 $24M History
David Witzke, Avidity Partners Management 0.28% New 0.28% 80,000 $1.8M History
George Soros, Soros Fund Management 0.01% New 0.01% 20,000 $441K History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by KLRA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KLRA insider trades
  • $327M bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Rtw Investments, LP 10% owner, +1 joint filer
    Buy
    $8M 500,000 shares at $16.00 +4.9% to stake
    Traded Apr 20 Filed Apr 22
    ↗
  2. Bain Capital Investors LLC 10% owner, +4 joint filers
    Buy
    $134M 8,398,438 shares at $16.00 +47% to stake
    Traded Apr 20 Filed Apr 20
    ↗
  3. Adam Koppel Director
    Buy
    $25M 1,562,500 shares at $16.00 +7.4% to stake
    Traded Apr 20 Filed Apr 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 9 conversions and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13D — Filing Doc
SCHEDULE 13D — Filing Doc
8-K 5.03,8.01,9.01 Filing Doc
424B4 Filing Doc
S-1/A Filing Doc
S-1 Filing Doc

Source: SEC EDGAR submissions, updated about 1 month ago. All on EDGAR

Financials

US-GAAP annual figures, as tagged in Form 10-K

Newly public, no 10-K financials yet. See the S-1/A.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Q2 2026

Period archive